[The HPA axis in the pathogenesis of chronic fatigue syndrome].
Ursini, F, Succurro, E, Grembiale, A et al. · La Clinica terapeutica · 2010
Quick Summary
This review examines whether problems with the HPA axis—a system in your brain and body that manages stress and energy—might explain ME/CFS symptoms. The HPA axis controls cortisol and other hormones that help your body respond to stress and maintain energy levels. This article summarizes what scientists have found so far about whether HPA axis dysfunction could be a key cause of ME/CFS.
Why It Matters
Understanding whether the HPA axis is dysfunctional in ME/CFS is crucial because it could point toward new diagnostic markers and treatments targeting hormone regulation. If HPA axis dysfunction is confirmed as part of ME/CFS pathogenesis, it might explain why patients experience persistent fatigue and why stress can worsen symptoms, potentially leading to more targeted therapeutic interventions.
Observed Findings
Multiple studies have documented abnormalities in HPA axis hormones (cortisol and other stress hormones) in ME/CFS patients
The pattern of hormone dysfunction differs from classic stress-response disorders
HPA axis abnormalities have been observed across different ME/CFS patient populations
The dysfunction may correlate with symptom severity in some patients
Inferred Conclusions
The HPA axis is a plausible biological target in ME/CFS pathogenesis warranting further investigation
HPA axis dysfunction may contribute to the characteristic fatigue and symptom patterns seen in ME/CFS
Systematic research into HPA axis mechanisms could yield insights into disease mechanisms and potential therapeutic targets
Remaining Questions
Is HPA axis dysfunction a primary cause of ME/CFS or a secondary consequence of the illness?
Which specific HPA axis abnormalities are most clinically relevant and consistent across patient populations?
Could HPA axis-targeted interventions improve ME/CFS symptoms, and would they be effective for all patients?
What This Study Does Not Prove
This review does not prove that HPA axis dysfunction causes ME/CFS—it only examines whether evidence supports a possible role. The study cannot establish whether any observed HPA axis abnormalities are a primary cause, a secondary consequence of illness, or simply a correlation. New empirical research is needed to determine causation and the clinical significance of HPA axis changes in ME/CFS patients.